Biotech Series C Investors & VC Firms
600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.
Tokyo University of Science Innovation Capital
TokyoPre-Seed–Growth
Birch Venture Capital, Inc.
Taipei CitySeed–Late Stage
5 people
JAFCO Asia
BeijingSeed–Late Stage$1M – $40M
9 people
Alium Capital
SydneySeed–Late Stage
6 people
Legendary Ventures, Llc.
New York CitySeed–Late Stage
6 people
NGN Capital
New YorkSeries A–Late Stage
6 people
Radar Ventures
Pre-Seed–Growth
Alpina Partners
MunichSeries A–Late Stage$635K – $2.5M
2 people
Build Ventures
HalifaxSeed–Series C
4 people
Black Marble Capital Management
TaipeiSeed–Late Stage
12 people
dsm-firmenich Venturing
MaastrichtPre-Seed–Late Stage$108K – $5.4M
9 people
Matū
AucklandPre-Seed–Growth
SBI Investment Korea Co. Ltd.
SeoulSeed–Late Stage$2.5M – $33M
Oost NL
ApeldoornSeed–Late Stage$108K – $5.4M
2 people
EFung Capital
ShenzhenSeed–Growth
GenerationS
MoscowSeed–Growth
Sanara Capital
Ra'ananaSeed–Late Stage
1 person
T. Rowe Price
BaltimoreSeed–Late Stage
1 person
Xerys
ParisSeed–Late Stage$16M – $97M
What If Ventures
FriscoPre-Seed–Late Stage
1 person
Quad Ventures
SeoulPre-Seed–Late Stage
4 people
INP Capital
VancouverSeed–Late Stage
5 people
MPCi (formerly Matrix Partners China)
SingaporeSeed–Growth
11 people
NEOM
RiyadhPre-Seed–Series C
11 people
Related lists
Series C Investors & VC Firms (2751)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)Biotech Investors & VC Firms in United States (1039)Series C Investors & VC Firms in United States (946)Biotech Series B Investors & VC Firms (900)Series C Investors & VC Firms in Global (896)Biotech Pre-Seed Investors & VC Firms (896)Healthtech Series C Investors & VC Firms (771)
Data sourced from public filings and firms' own websites — see our methodology.



















